NOBELPHARMA Trademark

Trademark Overview


On Friday, September 13, 2019, a trademark application was filed for NOBELPHARMA with the United States Patent and Trademark Office. The USPTO has given the NOBELPHARMA trademark a serial number of 79272876. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, July 15, 2025. This trademark is owned by Nobelpharma Co., Ltd.. The NOBELPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; ] pharmaceutical preparations for treating skin disorders [ ; vaccines; vaccines for treating malaria; pharmaceutical preparations for dysmenorrhea; pharmaceutical preparations for hypozincemia; pharmaceutical preparations for tympanic perforation; pharmaceutical preparations for sleep disorders; pharmaceutical preparations for pulmonary alveolar proteinosis; pharmaceutical preparations for distal myopathy; pharmaceutical preparations for CMV infection; pharmaceutical preparations for lymphatic disorder; pharmaceutical preparations for fibrodysplasia ossificans progressive; pharmaceutical preparations for Pendred syndrome ]
nobelpharma

General Information


Serial Number79272876
Word MarkNOBELPHARMA
Filing DateFriday, September 13, 2019
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, July 15, 2025
Registration Number6015978
Registration DateTuesday, March 24, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements


Description of the Colors ClaimedThe white word "Nobel" is written in the blue square and the word "pharma" is written in black; in addition, an under line is drawn in black below the blue square.
Goods and Services[ Pharmaceutical preparations for treating tympanic membrane perforation and ear canal soft tissue defect; ] pharmaceutical preparations for treating skin disorders [ ; vaccines; vaccines for treating malaria; pharmaceutical preparations for dysmenorrhea; pharmaceutical preparations for hypozincemia; pharmaceutical preparations for tympanic perforation; pharmaceutical preparations for sleep disorders; pharmaceutical preparations for pulmonary alveolar proteinosis; pharmaceutical preparations for distal myopathy; pharmaceutical preparations for CMV infection; pharmaceutical preparations for lymphatic disorder; pharmaceutical preparations for fibrodysplasia ossificans progressive; pharmaceutical preparations for Pendred syndrome ]
Pseudo MarkNOBEL PHARMA
Indication of Colors claimedThe color(s) blue, white and black is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNobelpharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 104-0033
JP

Party NameNobelpharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameNobelpharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, December 2, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, December 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2019NOTICE OF PUBLICATION
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Thursday, November 28, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, December 3, 2019ASSIGNED TO EXAMINER
Saturday, December 7, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, March 24, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, April 23, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, May 7, 2020FINAL DISPOSITION PROCESSED
Thursday, December 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 23, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 7, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 22, 2020NOTIFICATION PROCESSED BY IB
Thursday, December 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 7, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 24, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, April 17, 2025TEAS SECTION 71 RECEIVED
Tuesday, July 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 15, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, July 15, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED